| 查看: 925 | 回复: 11 | |||
[交流]
伊利诺伊大学芝加哥分校药学院诚聘博士后-生物材料,药物递送,细胞治疗,免疫治疗
|
|||
|
[About the Research Group] Dr. Zongmin Zhao’s Lab at University of Illinois at Chicago (UIC), College of Pharmacy is looking for a highly motivated postdoctoral researcher to join the interdisciplinary research team. The Zhao Lab focuses on innovating immunoengineering, cellular engineering, and drug delivery technologies to develop therapeutics for treating different diseases including cancer, infectious diseases, inflammation, drug addictions, and autoimmune diseases. Current projects in the Zhao Lab exploit genetic engineering, synthetic biology, immunology, biomaterials, and nanomedicine approaches to create translatable cellular therapeutics and immunotherapeutics. The PI’s work has been published in top journals including Cell, Nature Biomedical Engineering, Science Advances, PNAS, Advanced Materials, Biomaterials, Advanced Drug Delivery Reviews et al. More information about the Zhao Lab can be found at https://www.zongminzhao.com/. [About the University] UIC is a world-class, public institution that was ranked #36 among US universities by QS World University Rankings: USA. The College of Pharmacy at UIC has constantly been ranked Top-10 in the US by US News & World Report with a strong collaborative and innovative research community. The university is located in Chicago, home to a wide range of technology, science, and health-related companies. The Chicago area offers unique opportunities for collaboration and career development with both academia and industry. [About the Postdoc Position] We have an opening for a highly motivated postdoctoral fellow in the areas of cellular engineering, immunoengineering, and drug delivery. The postdoctoral fellow will have the opportunity to lead scientific projects and participate in grant writing, mentoring undergraduate and graduate students, and lab management. [Qualifications] 1) Ph.D. degree in Immunology, Cell Biology, Biomedical Engineering, Chemical Engineering, Chemistry, Pharmaceutical Sciences, or a related discipline by the time of appointment. 2) Expertise in two or more of the following areas: Viral or non-viral vector-based genetic engineering, gene editing, immunoengineering, cell therapy, biomaterials, microfluidics, computational Modeling, cancer research, animal models, drug delivery, and nanomedicine. Preference will be given to candidates who have background or trainings in immunology, cell biology, or molecular biology. 3) Additional expertise in in vivo experiments, mammalian cell culture, PCR, western blotting, flow cytometry, and molecular biology techniques will be preferable. 4) Strong track record of publications in high-impact journals. 5) Self-motivated and well organized. Strong oral and written communication skills. Be able to conduct research independently and to work collaboratively with other fellows and students in the lab. [How to Apply] Postdoctoral candidates should send a CV, a cover letter describing their research background and interest, and the name and contact information of three references to Dr. Zhao (zhaozm@uic.edu). |
» 猜你喜欢
售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急
已经有4人回复
寻找合作团队
已经有3人回复
售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急
已经有4人回复
售一区SCI文章T0P,我:8O.551.O54,科目全,可十急
已经有6人回复
售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急
已经有4人回复
同一个分子,一条来自文献,一条来自AI——不告诉你答案,你会选哪条?
已经有9人回复
售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急
已经有4人回复
售一区SCI文章T0P,我:8O.551.O54,科目全,可十急
已经有4人回复
售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急
已经有8人回复
售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急
已经有4人回复
» 本主题相关商家推荐: (我也要在这里推广)
2楼2021-12-04 13:31:25
12楼2021-12-06 10:44:45
简单回复
f418983楼
2021-12-04 13:34
回复
海田014楼
2021-12-04 14:00
回复
zongmzhao(金币+2): 谢谢参与
f 发自小木虫IOS客户端
tzynew5楼
2021-12-04 14:06
回复
zongmzhao(金币+2): 谢谢参与
o 发自小木虫Android客户端
2021-12-04 15:43
回复
zongmzhao(金币+2): 谢谢参与
nono20097楼
2021-12-04 15:57
回复
zongmzhao(金币+2): 谢谢参与
。 发自小木虫Android客户端
kingluck8楼
2021-12-04 22:44
回复
zongmzhao(金币+2): 谢谢参与
2021-12-04 22:48
回复
zongmzhao(金币+2): 谢谢参与
shenrenren10楼
2021-12-05 08:02
回复
zongmzhao(金币+2): 谢谢参与
曾经沧海a11楼
2021-12-05 11:10
回复
zongmzhao(金币+2): 谢谢参与










回复此楼